Products

What will AGI do for Acetaminophen/aspirin/caffeine/calcium gluconate?

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN103. This VA Drug Class (CN103) classifies this compound as belonging to the group NON-OPIOID ANALGESICS. The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate. The European Medicines Agency schedules Acetaminophen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09611MIG. The World Health Organization schedules acetaminophen in its Anatomical Therapeutic Chemical (ATC) Classification. The second component of this combination drug is a cyclooxygenase inhibitor with the molecular formula C9H8O4, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier R16CO5Y76E, chemically known as salicylic acid, acetyl- but more generally known as acetylsalicylic acid, which bears U.S. National Institutes of Health Compound Identifier 2244. The European Medicines Agency schedules Acetylsalicylic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12730MIG. The World Health Organization schedules acetylsalicylic acid in its Anatomical Therapeutic Chemical (ATC) Classification. The third component of this combination drug is a cns stimulant and bioactive food component with the molecular formula C8H10N4O2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 3G6A5W338E, chemically known as 1,3,7-trimethylxanthine but more generally known as caffeine, which bears U.S. National Institutes of Health Compound Identifier 2519. caffeine comes in many forms, including base, benzoate, benzoate sodium, bromide, citrate, hydrobromide, hydrochloride, hydroiodide, monohydrate, salicylate, sodium benzoate, sodium benzoicum, and sodium salicylate. The European Medicines Agency schedules Caffeine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13146MIG. The World Health Organization schedules caffeine in its Anatomical Therapeutic Chemical (ATC) Classification. The fourth component of this combination drug is an electrolyte replacement agent with the molecular formula 2C6H11O7.Ca, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier SQE6VB453K, chemically known as gluconic acid, calcium salt but more generally known as calcium gluconate, which bears U.S. National Institutes of Health Compound Identifier 9290. The European Medicines Agency schedules Calcium gluconate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13176MIG. The World Health Organization schedules calcium gluconate in its Anatomical Therapeutic Chemical (ATC) Classification.